Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen Trudeau

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Breast Cancer Research and Treatment|May 4, 2017
The role of quantitative estrogen receptor status in predicting tumor response at surgery in breast cancer patients treated with neoadjuvant chemotherapyJacques Raphael, Sonal Gandhi, Nim Li, et al.
Cancer Treatment Reviews|January 1, 2008
Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic reviewAndrea Eisen, Maureen Trudeau, Wendy Shelley, et al.
Cureus|May 23, 2020
Development and Testing of an Adjuvant Radiotherapy Decision Aid for Older Women Diagnosed with Stage I Breast Cancer: A Pilot StudyMatt Neve, Nayanee Henry-Noel, Rajin Mehta, et al.
Breast Cancer Research and Treatment|June 1, 2015
Adjuvant taxane-based chemotherapy for early stage breast cancer: a real-world comparison of chemotherapy regimens in OntarioSofia Torres, Maureen Trudeau, Andrea Eisen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Cost-effectiveness of the 21-gene assay for guiding adjuvant chemotherapy decisions in early breast cancerMike Paulden, Jacob Franek, Ba' Pham, et al.
Springerplus|February 16, 2016
Patterns in target-directed breast cancer researchSofia Torres, Christine Simmons, Jean-François Boileau, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Appraising Adjuvant Endocrine Therapy in Hormone Receptor Positive HER2-Negative Breast Cancer-A Literature ReviewDanilo Giffoni de Mello Morais Mata, Carlos Amir Carmona, Andrea Eisen, et al.
Cancer Treatment Reviews|May 27, 2008
Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: a systematic reviewYolanda Madarnas, Maureen Trudeau, Jacob A Franek, et al.
The Oncologist|March 10, 2015
The value of personalizing medicine: medical oncologists' views on gene expression profiling in breast cancer treatmentYvonne Bombard, Linda Rozmovits, Maureen Trudeau, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2016
The influence of gene expression profiling on decisional conflict in decision making for early-stage breast cancer chemotherapyKaren V MacDonald, Yvonne Bombard, Ken Deal, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Breast Cancer Research and Treatment|May 4, 2017
The role of quantitative estrogen receptor status in predicting tumor response at surgery in breast cancer patients treated with neoadjuvant chemotherapyJacques Raphael, Sonal Gandhi, Nim Li, et al.
Cancer Treatment Reviews|January 1, 2008
Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic reviewAndrea Eisen, Maureen Trudeau, Wendy Shelley, et al.
Cureus|May 23, 2020
Development and Testing of an Adjuvant Radiotherapy Decision Aid for Older Women Diagnosed with Stage I Breast Cancer: A Pilot StudyMatt Neve, Nayanee Henry-Noel, Rajin Mehta, et al.
Breast Cancer Research and Treatment|June 1, 2015
Adjuvant taxane-based chemotherapy for early stage breast cancer: a real-world comparison of chemotherapy regimens in OntarioSofia Torres, Maureen Trudeau, Andrea Eisen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Cost-effectiveness of the 21-gene assay for guiding adjuvant chemotherapy decisions in early breast cancerMike Paulden, Jacob Franek, Ba' Pham, et al.
Springerplus|February 16, 2016
Patterns in target-directed breast cancer researchSofia Torres, Christine Simmons, Jean-François Boileau, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Appraising Adjuvant Endocrine Therapy in Hormone Receptor Positive HER2-Negative Breast Cancer-A Literature ReviewDanilo Giffoni de Mello Morais Mata, Carlos Amir Carmona, Andrea Eisen, et al.
Cancer Treatment Reviews|May 27, 2008
Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: a systematic reviewYolanda Madarnas, Maureen Trudeau, Jacob A Franek, et al.
The Oncologist|March 10, 2015
The value of personalizing medicine: medical oncologists' views on gene expression profiling in breast cancer treatmentYvonne Bombard, Linda Rozmovits, Maureen Trudeau, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2016
The influence of gene expression profiling on decisional conflict in decision making for early-stage breast cancer chemotherapyKaren V MacDonald, Yvonne Bombard, Ken Deal, et al.
Pageof 11